Alkermes plc (NASDAQ: ALKS) Loses -18.70% From High. Why That Could Change?
Currently, there are 166.98M common shares owned by the public and among those 164.62M shares have been available to trade. The company’s stock has a 5-day price change of -0.15% and -9.70% over the past three months. ALKS shares are trading -3.64% year to date (YTD), with the 12-month market performance down to -1.59% lower. […]
Alkermes plc (ALKS): Insights At A Glance
Alkermes plc (ALKS) concluded trading on Thursday at a closing price of $32.56, with 5.47 million shares of worth about $178.1 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 20.82% during that period and on Thursday the price saw a gain of about […]
Value Hunters: Look To Alkermes plc (ALKS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Alkermes plc (NASDAQ:ALKS). The institutional investor has increased its shareholding in the Healthcare company by 0.37% to 18.19 million shares with purchase of 66410.0 shares. This fresh investment now brings its stake to 10.90% valued currently at $439.16 million. In addition, BlackRock Fund […]
Alkermes plc (NASDAQ: ALKS) Loses -15.98% From High. Why That Could Change?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Alkermes plc (NASDAQ:ALKS). The institutional investor has increased its shareholding in the Healthcare company by 0.37% to 18.19 million shares with purchase of 66410.0 shares. This fresh investment now brings its stake to 10.90% valued currently at $440.07 million. In addition, BlackRock Fund […]
